Brief: Dimerix Ltd Entered Into Exclusive License Agreement
05/10/2023 02:31
Oct 5 (Reuters) - Dimerix Ltd DXB.AX :
* ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT FOR EUROPEAN
ECONOMIC AREA, UK, SWITZERLAND, CANADA, AUSTRALIA, AND NEW
ZEALAND
* TO RECEIVE UP TO AU$230 MILLION IN UPFRONT AND MILESTONE
PAYMENTS, PLUS ROYALTIES
* DIMERIX RETAINS ALL RIGHTS TO DMX-200 IN ALL OTHER
TERRITORIES
Source text for Eikon: ID:nASX2YPWPW
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions